Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QD-Mic
- Development stage
- Preclinical
- Lead developer
- Northeastern University
- Modality
- Nanoparticles → Drug Delivery Systems, Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
QD-Mic refers to quantum dot-loaded immunomicelles designed for targeted tumor imaging. These nanoparticles are composed of near-infrared quantum dots encapsulated within polymeric micelles prepared from a polyethylene glycol-phosphatidylethanolamine (PEG-PE) conjugate. The surface of the micelle is functionalized with the cancer-specific monoclonal anti-nucleosome antibody 2C5 (mAb 2C5), which recognizes tumor-surface-bound nucleosomes. This targeted delivery system enhances the accumulation of the imaging agent in tumor tissues, providing significantly higher fluorescence intensity compared to non-targeted formulations, thereby improving the sensitivity and specificity of optical tumor detection in preclinical models.
- Other names
- Quantum dot loaded immunomicelles2C5-QD-Mic2C5-coupled QD-containing polymeric micelles
Beyond the preview
Go deeper on QD-Mic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QD-Mic.